Phase II Trial of VDJ001 in Patients With Moderate-to-severe Active Rheumatoid Arthritis
Condition: Rheumatoid Arthritis Intervention: Biological: Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection Sponsor: Xiaoming Gong Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials